The commensal intestinal microbiota of humans and animals may act as a reservoir of antibiotic resistance genes that could ultimately be transferred to pathogens (15, 18) ; in fact, gene transfer between bacterial species in the gastrointestinal tracts (GIT) of mammals is known to occur (11) . Bifidobacteria are among the dominant populations of the human GIT microbiota, where they are thought to play a pivotal role in maintaining the microbial balance necessary for intestinal health (19) . Bifidobacterial strains are therefore frequently used as probiotics in the prophylaxis and therapy of GIT disorders (12) . This practice, however, requires that they be screened for acquired antibiotic resistance determinants if the latter are not to be propagated through the food chain (14, 15, 18) .
Tetracyclines inhibit protein synthesis by preventing the attachment of aminoacyl-tRNA to the bacterial ribosome (2) . The broad-spectrum antimicrobial properties of these agents, the absence of major adverse side effects, and their low price have led to their intensive use not only in the treatment of human and animal infections but also as prophylactic agents and growth promoters in livestock raising and aquaculture (2) . This extensive use has promoted the appearance of resistance and its spread by horizontal acquisition (2, 13) . Resistance is mediated through efflux proteins, ribosomal protection proteins, or antibiotic-inactivating enzymes (for a review, see reference 13).
The tet(W) gene, which encodes a ribosomal protection protein, has recently been described for a wide range of gram-positive and gram-negative bacteria (1, 2), including bifidobacteria (7, 10, 17) . This gene has been associated with a conjugative transposon (TnB1230) in Butyrivibrio fibrisolvens (9) that has been shown to transfer at high frequencies (up to 5.1 ϫ 10 Ϫ3 transconjugants per recipient) (16) .
In a recent survey, a microbroth assay showed atypical (Ն16 g ml Ϫ1 ) MICs of tetracycline for human bifidobacterial strains isolated from fecal samples of healthy adults without a recent history of antibiotic treatment (4) . The object of this study was to investigate the nature and molecular organization of the tetracycline determinant encoding this resistance.
MICs of tetracycline for bifidobacteria. The MICs of tetracycline for a series of susceptible (14 isolates) and resistant (16 isolates) bifidobacterial species which had been assayed by microdilution (4) were precisely determined by Etest (AB Biodisk, Solna, Sweden). Assays were performed in LSM test agar (6) (90% IsoSensitest, 10% MRS, 1.5% agar; all from Oxoid, New Hampshire, United Kingdom) supplemented with 0.3 g of cysteine liter
Ϫ1 . Plates were incubated at 37°C for 48 h in an anaerobic chamber (atmosphere, 10% H 2 -10% CO 2 -80% N 2 ). The MICs for susceptible isolates ranged from 0.25 to 1 g ml Ϫ1 , whereas those for isolates thought to be resistant ranged from 4 to 32 g ml Ϫ1 . MICs obtained for the same strains in duplicate experiments never exceeded 1 order of dilution.
To exclude the analysis of replicates, resistant and susceptible isolates were typed by rapid amplification of polymorphic DNA (RAPD) analysis by PCR. Amplifications were performed using primer OPA18 and PCR conditions described elsewhere (8) . Seven different RAPD-PCR profiles identifying distinct strains were obtained among the resistant isolates, as follows: Bifidobacterium longum (11 isolates, 5 strains), Bifidobacterium bifidum (5 isolates, 1 strain), and Bifidobacterium animalis subsp. animalis (1 isolate, 1 strain).
Amplification and analysis of tetracycline resistance genes. The presence of genes encoding ribosomal protection proteins was checked among resistant and susceptible strains by PCR with two pairs of degenerate primers: DI-DII (3) and Tet1-Tet2 (1). Resistant strains all yielded a single PCR product of the same size when either of the primer pairs was used. Surprisingly, positive amplification was also obtained with DNA from the susceptible strain B. longum M21. Additional PCR assays were then performed with primers TetWF and Tet2, specific for tet(W) (17) , and primers DI and TetMR, specific for tet(M) (5) . No DNA was amplified from either resistant or susceptible isolates with primers for tet (M) . In contrast, a product of about 1,250 bp was obtained for all 16 resistant isolates when primers for tet(W) were used. Purified amplicons were sequenced and the resulting sequences analyzed and compared to others held in public databases.
Analysis of the nucleotide sequences showed them to share Ͼ99.8% identity. Comparison of the sequences showed a high degree of similarity at the nucleotide level to several tetracycline resistance genes. In particular, complete identity was seen with an internal segment of the tet(W) gene from B. fibrisolvens (1) . Based on this homology, primers TetWSacF (5Ј-CCCTG GAGCTCATGCTCATGTAC-3Ј) and TetWSacR (5Ј-CCAT CGGAGCTCCATAACTTCTG-3Ј) were designed to amplify the whole gene and its surrounding promoter and terminator regions. Positive amplification was obtained only when DNA from the resistant strains was used as a template, suggesting that the susceptible strain may harbor a shortened (nonfunctional) version of the gene. The amplicon was cloned into pUC19 and introduced into Escherichia coli, which became resistant to tetracycline (MIC, 64 g ml Ϫ1 ). The insert was then double-strand sequenced. At the nucleotide level, analysis of a 2,589-bp segment showed that the sequence was identical to that of B. fibrisolvens 1.230 (1, 9), except for a single oligonucleotide change in the coding region leading to a conservative amino acid replacement in its deduced Tet(W) protein. Further, the B. longum H66 sequence was found to share around 98% identity to recently reported tet(W) genes from bifidobacterial species (GenBank accession no. AF202986) (7, 17) . A phylogenetic tree showing the relationships of the deduced Tet(W) proteins and those of other ribosome protection proteins is depicted in Fig. 1 . The presence of resistance genes with nearly identical nucleotide and protein sequences in unrelated bacterial and bifidobacterial species suggests that recent horizontal transfer has occurred (1, 16) . Intriguing is the fact that different MICs are repeatedly reported for identical genes (7, 10, 17) . Multiple loci, different expression levels of tet(W), and/or the influence of the genetic background of the strains may account for the phenotypic differences.
Location of the tet(W) gene. The genetic location of tet(W) in the distinct species was assessed by hybridization using as a probe a 1.2-kbp internal segment of the gene obtained by PCR and labeled with digoxigenin (Roche Applied Science, Basel, Switzerland). Total and plasmid DNAs digested with the restriction enzymes EcoRI and HindIII (Roche) were hybridized using high-stringency standard conditions (hybridization at 68°C and two final washing steps in 0.5ϫ SSC [1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate]-0.1% SDS at 68°C for 15 min). Figure 2 shows the results obtained with EcoRI-digested total DNA. A positive hybridization signal was obtained with all tetracycline-resistant strains and, as expected, with the susceptible strain M21. The hybridization signal appeared at a different position in each of the strains (estimated sizes, 2.5 to 16 kbp), except for the related strains B. longum B93 and B94 (displaying distinct RAPD-PCR patterns but isolated from the same individual). This suggests that the genetic organization of the loci might be different in each strain. The tet(W) locus is thought to be located on the bacterial chromosome, since only FIG. 1. Phylogenetic tree showing the evolutionary relationships of complete Tet(W) and other ribosome protection proteins from tetracyclineresistant bacteria. GenBank accession numbers for the nucleotide sequences used to derive amino acid sequences are given in parentheses. The rooted neighbor-joining tree was generated using DNAman software (Lynnon Corporation, Vaudreuil-Dorion, Quebec, Canada). Numbers beside nodes indicate bootstrap values when these are greater than 95% (based on 500 trials). Bar, 0.05% difference in amino acid sequence. (9, 17) , primers based on transposon sequences were also synthesized and used in PCR experiments. However, no amplification products were obtained with any strain, suggesting that there are no sequences related to this mobile unit in these Bifidobacterium species. Further, preliminary inverse-PCR experiments indicate that tet(W) is inserted into a putative open reading frame encoding a permease (GenBank accession no. AE014295) of an ABC transporter system in B. longum NCC2705 (data not shown).
In conclusion, these and other results indicate that dominant Bifidobacterium species from the human GIT frequently harbor acquired tetracycline resistance encoded by a tet(W) gene. The fact that genes from Bifidobacterium showed more nucleotide changes than those from species of different genera strongly suggests independent transfer events. The spread of this gene among cattle rumen and human GIT organisms may be occurring very rapidly by unknown mechanisms that merit further research. However, preliminary conjugation experiments showed that tetracycline resistance from B. longum H66 and L42 did not transfer to susceptible strains (data not shown). Once acquired, genes could either be stably maintained in the absence of antibiotic selection or selected by continued exposure to antibiotics through dietary intake (5) .
Nucleotide sequence accession number. The nucleotide sequence of the tet(W) gene and its surrounding regions from B. longum H66 has been deposited in GenBank (accession no. DQ060146). 
